The potential involvement of the JAK2-NLRP3 axis, implicated in melanoma regulation and immune modulation, further emphasizes the complexity and breadth of MBP’s therapeutic actions by modulating JAK/STAT pathways [42]. This evidence concerns the gene JAK2 and melanoma.